Winter H, Dräger E, Sterry W
Department of Dermatology, Charité University Medical Center, Humboldt-University of Berlin, Berlin, Germany.
Dermatol Surg. 2000 Feb;26(2):105-8. doi: 10.1046/j.1524-4725.2000.98012.x.
While sclerotherapy in chronic venous insufficiency and in hemorrhoids is well established, the use of sclerotherapy for hemangiomas of the skin is widely unknown.
The aim of the study was to analyze the clinical value of sclerotherapy with polidocanol in a larger population.
Over a period of 20 years (1975-1995) we performed sclerotherapy of hemangiomas and vascular malformations in a total of 157 patients. Their ages ranged from 3 months to 75 years. Among these were 87 (55.4%) children and adolescents (up to the age of 18). Sclerotherapy with polidocanol was carried out mostly at monstrous or rapidly growing cavernous hemangiomas mainly localized in the face.
One to three injections was usually sufficient to obtain the sclerosis effect; aesthetically, long-term results were convincing. Severe complications were not observed.
Sclerotherapy of hemangiomas is a relatively simple, effective, and inexpensive method that is a valuable and promising treatment.
虽然硬化疗法在慢性静脉功能不全和痔疮治疗中已得到广泛应用，但用于皮肤血管瘤的硬化疗法却鲜为人知。
本研究旨在分析在更大规模人群中使用聚多卡醇进行硬化疗法的临床价值。
在20年期间（1975 - 1995年），我们对总共157例血管瘤和血管畸形患者进行了硬化治疗。他们的年龄从3个月到75岁不等。其中有87例（55.4%）儿童和青少年（18岁以下）。聚多卡醇硬化疗法主要用于治疗主要位于面部的巨大或快速生长的海绵状血管瘤。
通常注射一至三次就足以获得硬化效果；从美学角度来看，长期效果令人满意。未观察到严重并发症。
血管瘤硬化疗法是一种相对简单、有效且廉价的方法，是一种有价值且有前景的治疗方法。
